Switch to:
More From Other Websites
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT® for Migraines in... Apr 13 2017
IntelGenx and RedHill Biopharma Announce Marketing Approval of RIZAPORT(R) for Migraines in... Apr 13 2017
IntelGenx Files Preliminary Short Form Prospectus in Connection With a Proposed Offering of... Apr 05 2017
IntelGenx Presents at the 13th International Conference on Alzheimer's and Parkinson's Diseases Apr 04 2017
IntelGenx and Tetra Bio-Pharma Announce the Signing of a Definitive Agreement for the Development... Apr 03 2017
IntelGenx Technologies Corp. :IGXT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 30, 2017 Mar 30 2017
IntelGenx Reports Fourth Quarter and Full-Year 2016 Financial Results Mar 28 2017
Oral Film Exclusivity Granted to IntelGenx' VersaFilm(TM) for Tadalafil Erectile Dysfunction Dosing... Mar 28 2017
IntelGenx to Report Fourth Quarter and Full Year 2016 Financial Results on March 28, 2017 -... Mar 21 2017
IntelGenx Engages Kilmer Lucas for Cross-Border Investor Relations Mar 13 2017
Research Reports Initiated on Healthcare Stocks Aphria, Antibe Therapeutics, BriaCell Therapeutics,... Mar 07 2017
IntelGenx and Tetra Bio-Pharma Announce the Signing of a Term Sheet for the Development and... Feb 09 2017
IntelGenx Presentation Now Available for On-Demand Viewing Feb 06 2017
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present... Jan 30 2017
IntelGenx to Webcast, Live, at VirtualInvestorConferences.com February 2 Jan 30 2017
IntelGenx Grants Stock Options Jan 19 2017
IntelGenx Announces Definitive Agreement with Chemo Group for a Generic CNS Tablet Jan 04 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK